SATB2 and colorectal carcinoma: Through transcriptomic and immunohistochemical analyses, SATB2 was also detected in CRC tissues, although its expression levels were markedly lower than those in normal tissues, which suggested that SATB2 might function as a tumor suppressor in CRC.